MACERICH CO/THE (MAC) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:MAC • US5543821012

19.215 USD
-0.41 (-2.06%)
Last: Feb 9, 2026, 01:58 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

MAC gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 122 industry peers in the Diversified REITs industry. Both the profitability and financial health of MAC have multiple concerns. MAC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • MAC had negative earnings in the past year.
  • MAC had a positive operating cash flow in the past year.
  • MAC had negative earnings in 4 of the past 5 years.
  • Each year in the past 5 years MAC had a positive operating cash flow.
MAC Yearly Net Income VS EBIT VS OCF VS FCFMAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

  • With a Return On Assets value of -4.63%, MAC is not doing good in the industry: 81.15% of the companies in the same industry are doing better.
  • MAC's Return On Equity of -15.55% is on the low side compared to the rest of the industry. MAC is outperformed by 77.87% of its industry peers.
  • MAC's Return On Invested Capital of 1.79% is on the low side compared to the rest of the industry. MAC is outperformed by 69.67% of its industry peers.
  • MAC had an Average Return On Invested Capital over the past 3 years of 1.71%. This is in line with the industry average of 3.07%.
  • The 3 year average ROIC (1.71%) for MAC is below the current ROIC(1.79%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -4.63%
ROE -15.55%
ROIC 1.79%
ROA(3y)-2.25%
ROA(5y)-1.82%
ROE(3y)-6.88%
ROE(5y)-6.09%
ROIC(3y)1.71%
ROIC(5y)1.43%
MAC Yearly ROA, ROE, ROICMAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

  • Looking at the Operating Margin, with a value of 17.50%, MAC is in line with its industry, outperforming 40.98% of the companies in the same industry.
  • In the last couple of years the Operating Margin of MAC has declined.
  • The Gross Margin of MAC (54.86%) is worse than 70.49% of its industry peers.
  • MAC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 17.5%
PM (TTM) N/A
GM 54.86%
OM growth 3Y6.69%
OM growth 5Y-4.17%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.18%
GM growth 5Y-2.5%
MAC Yearly Profit, Operating, Gross MarginsMAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • MAC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, MAC has more shares outstanding
  • The number of shares outstanding for MAC has been increased compared to 5 years ago.
  • The debt/assets ratio for MAC is higher compared to a year ago.
MAC Yearly Shares OutstandingMAC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
MAC Yearly Total Debt VS Total AssetsMAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

  • MAC has an Altman-Z score of 0.07. This is a bad value and indicates that MAC is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of MAC (0.07) is worse than 74.59% of its industry peers.
  • MAC has a Debt/Equity ratio of 2.02. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of MAC (2.02) is worse than 69.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.02
Debt/FCF N/A
Altman-Z 0.07
ROIC/WACC0.28
WACC6.33%
MAC Yearly LT Debt VS Equity VS FCFMAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

  • MAC has a Current Ratio of 0.85. This is a bad value and indicates that MAC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • MAC has a Current ratio (0.85) which is in line with its industry peers.
  • MAC has a Quick Ratio of 0.85. This is a bad value and indicates that MAC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • MAC has a Quick ratio (0.85) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 0.85
Quick Ratio 0.85
MAC Yearly Current Assets VS Current LiabilitesMAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • MAC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -596.88%.
  • Looking at the last year, MAC shows a decrease in Revenue. The Revenue has decreased by -6.05% in the last year.
  • MAC shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.20% yearly.
EPS 1Y (TTM)-596.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%32%
Revenue 1Y (TTM)-6.05%
Revenue growth 3Y2.71%
Revenue growth 5Y-0.2%
Sales Q2Q%15%

3.2 Future

  • The Earnings Per Share is expected to grow by 16.72% on average over the next years. This is quite good.
  • Based on estimates for the next years, MAC will show a small growth in Revenue. The Revenue will grow by 5.17% on average per year.
EPS Next Y31.55%
EPS Next 2Y33.76%
EPS Next 3Y24.42%
EPS Next 5Y16.72%
Revenue Next Year19.6%
Revenue Next 2Y8.81%
Revenue Next 3Y6.14%
Revenue Next 5Y5.17%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MAC Yearly Revenue VS EstimatesMAC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M 800M 1B
MAC Yearly EPS VS EstimatesMAC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 1 -1 2 3

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • MAC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year MAC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MAC Price Earnings VS Forward Price EarningsMAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MAC indicates a slightly more expensive valuation: MAC is more expensive than 72.95% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 18.03
MAC Per share dataMAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

  • A more expensive valuation may be justified as MAC's earnings are expected to grow with 24.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.76%
EPS Next 3Y24.42%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 3.47%, MAC has a reasonable but not impressive dividend return.
  • MAC's Dividend Yield is slightly below the industry average, which is at 6.81.
  • MAC's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 3.47%

5.2 History

  • The dividend of MAC decreases each year by -25.88%.
  • MAC has paid a dividend for at least 10 years, which is a reliable track record.
  • MAC has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-25.88%
Div Incr Years0
Div Non Decr Years3
MAC Yearly Dividends per shareMAC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

  • The earnings of MAC are negative and hence is the payout ratio. MAC will probably not be able to sustain this dividend level.
DP-43.75%
EPS Next 2Y33.76%
EPS Next 3Y24.42%
MAC Yearly Income VS Free CF VS DividendMAC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

More info and screens

Find the best dividend stocksShow peers with best dividend

MACERICH CO/THE

NYSE:MAC (2/9/2026, 1:58:00 PM)

19.215

-0.41 (-2.06%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-05
Earnings (Next)05-11
Inst Owners103.36%
Inst Owner Change-1.19%
Ins Owners0.31%
Ins Owner Change-0.06%
Market Cap4.92B
Revenue(TTM)1.03B
Net Income(TTM)-390.44M
Analysts70
Price Target20.33 (5.8%)
Short Float %6.11%
Short Ratio8.91
Dividend
Industry RankSector Rank
Dividend Yield 3.47%
Yearly Dividend0.64
Dividend Growth(5Y)-25.88%
DP-43.75%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-207.67%
Min EPS beat(2)-320.79%
Max EPS beat(2)-94.54%
EPS beat(4)0
Avg EPS beat(4)-629.5%
Min EPS beat(4)-1955.13%
Max EPS beat(4)-94.54%
EPS beat(8)2
Avg EPS beat(8)-194.09%
EPS beat(12)3
Avg EPS beat(12)-347.67%
EPS beat(16)3
Avg EPS beat(16)-307.05%
Revenue beat(2)2
Avg Revenue beat(2)1.68%
Min Revenue beat(2)0.51%
Max Revenue beat(2)2.85%
Revenue beat(4)4
Avg Revenue beat(4)9.55%
Min Revenue beat(4)0.51%
Max Revenue beat(4)22.66%
Revenue beat(8)7
Avg Revenue beat(8)6.43%
Revenue beat(12)10
Avg Revenue beat(12)4.74%
Revenue beat(16)13
Avg Revenue beat(16)4.29%
PT rev (1m)2.2%
PT rev (3m)1.6%
EPS NQ rev (1m)-8.56%
EPS NQ rev (3m)-31.41%
EPS NY rev (1m)-19.33%
EPS NY rev (3m)-45.15%
Revenue NQ rev (1m)-3.24%
Revenue NQ rev (3m)-3.54%
Revenue NY rev (1m)-1.5%
Revenue NY rev (3m)-1.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.8
P/FCF N/A
P/OCF 15.08
P/B 1.96
P/tB 2.13
EV/EBITDA 18.03
EPS(TTM)-1.59
EYN/A
EPS(NY)-0.17
Fwd EYN/A
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)1.27
OCFY6.63%
SpS4.01
BVpS9.8
TBVpS9.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.63%
ROE -15.55%
ROCE 2.27%
ROIC 1.79%
ROICexc 1.86%
ROICexgc 1.94%
OM 17.5%
PM (TTM) N/A
GM 54.86%
FCFM N/A
ROA(3y)-2.25%
ROA(5y)-1.82%
ROE(3y)-6.88%
ROE(5y)-6.09%
ROIC(3y)1.71%
ROIC(5y)1.43%
ROICexc(3y)1.73%
ROICexc(5y)1.46%
ROICexgc(3y)1.79%
ROICexgc(5y)1.51%
ROCE(3y)2.16%
ROCE(5y)1.81%
ROICexgc growth 3Y9.63%
ROICexgc growth 5Y-3.26%
ROICexc growth 3Y9.11%
ROICexc growth 5Y-3.53%
OM growth 3Y6.69%
OM growth 5Y-4.17%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.18%
GM growth 5Y-2.5%
F-Score4
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 2.02
Debt/FCF N/A
Debt/EBITDA 9.33
Cap/Depr 122.66%
Cap/Sales 43.58%
Interest Coverage 0.87
Cash Conversion 59.96%
Profit Quality N/A
Current Ratio 0.85
Quick Ratio 0.85
Altman-Z 0.07
F-Score4
WACC6.33%
ROIC/WACC0.28
Cap/Depr(3y)47.12%
Cap/Depr(5y)31.57%
Cap/Sales(3y)15.89%
Cap/Sales(5y)10.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-596.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%32%
EPS Next Y31.55%
EPS Next 2Y33.76%
EPS Next 3Y24.42%
EPS Next 5Y16.72%
Revenue 1Y (TTM)-6.05%
Revenue growth 3Y2.71%
Revenue growth 5Y-0.2%
Sales Q2Q%15%
Revenue Next Year19.6%
Revenue Next 2Y8.81%
Revenue Next 3Y6.14%
Revenue Next 5Y5.17%
EBIT growth 1Y-8%
EBIT growth 3Y9.58%
EBIT growth 5Y-4.36%
EBIT Next Year222.29%
EBIT Next 3Y48.88%
EBIT Next 5Y27.61%
FCF growth 1Y-165.99%
FCF growth 3Y-40.36%
FCF growth 5Y-30.47%
OCF growth 1Y9.27%
OCF growth 3Y-0.35%
OCF growth 5Y-4.41%

MACERICH CO/THE / MAC FAQ

What is the fundamental rating for MAC stock?

ChartMill assigns a fundamental rating of 1 / 10 to MAC.


Can you provide the valuation status for MACERICH CO/THE?

ChartMill assigns a valuation rating of 1 / 10 to MACERICH CO/THE (MAC). This can be considered as Overvalued.


How profitable is MACERICH CO/THE (MAC) stock?

MACERICH CO/THE (MAC) has a profitability rating of 2 / 10.


What is the financial health of MACERICH CO/THE (MAC) stock?

The financial health rating of MACERICH CO/THE (MAC) is 0 / 10.